Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria

[1] Contou R(2012)CTX-M enzymes: origin and diffusion Front Microbiol 2 110-142

[2] Gonzalez-Alba J(2012)Current epidemiology and growing resistance of gram negative pathogens Korean J Intern Med 27 128-712

[3] Galian J(2008)Molecular epidemiology of extended-spectrum-lactamases among J Clin Microbiol 46 707-2622

[4] Livermore D(2010) isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006 J Clin Microbiol 48 2618-920

[5] Fang H(2007)Evaluation of a commercial microarray system for detection of SHV, TEM, CTX-M and KPC-type beta lactamase genes in Gram negative isolates J Antimicrob Chemother 60 913-1262

[6] Ataker F(2006)Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis Antimicrob Agents Chemother 50 1257-19

[7] Hedin G(2013)Clinical and economic impact of bacteremia with extended-spectrum beta-lactamase-producing Enterobacteriaceae J Med Bacteriol 2 12-39

[8] Dornbusch K(2016)The frequency of extended-spectrum beta-lactamase (ESBL) in Ann Clin Microbiol Antimicrob 15 29-288

[9] Endimiani A(2017) and N Y Sci J 10 29-51

[10] Hujer A(2009): a report from Mashhad, Iran Pak J Sci 25 279-16

[1] Contou R(2012)CTX-M enzymes: origin and diffusion Front Microbiol 2 110-142

[2] Gonzalez-Alba J(2012)Current epidemiology and growing resistance of gram negative pathogens Korean J Intern Med 27 128-712

[3] Galian J(2008)Molecular epidemiology of extended-spectrum-lactamases among J Clin Microbiol 46 707-2622

[4] Livermore D(2010) isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006 J Clin Microbiol 48 2618-920

[5] Fang H(2007)Evaluation of a commercial microarray system for detection of SHV, TEM, CTX-M and KPC-type beta lactamase genes in Gram negative isolates J Antimicrob Chemother 60 913-1262

[6] Ataker F(2006)Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis Antimicrob Agents Chemother 50 1257-19

[7] Hedin G(2013)Clinical and economic impact of bacteremia with extended-spectrum beta-lactamase-producing Enterobacteriaceae J Med Bacteriol 2 12-39

[8] Dornbusch K(2016)The frequency of extended-spectrum beta-lactamase (ESBL) in Ann Clin Microbiol Antimicrob 15 29-288

[9] Endimiani A(2017) and N Y Sci J 10 29-51

[10] Hujer A(2009): a report from Mashhad, Iran Pak J Sci 25 279-16